Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1 5Phase 3 2Phase 1/2 1

Status

Completed 23Terminated 5Unknown 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 3Breast 2Thoracic 1Sarcoma 1Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2Breast Neoplasms 2Sarcoma 1Pancreatic Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Colonic Neoplasms 1Advanced Solid Tumors 1

Interventions

Cyclophosphamide 98pembrolizumab 85Gemcitabine 81Carboplatin 62fludarabine 61Nivolumab 57Cisplatin 54Paclitaxel 51Radiotherapy 50Docetaxel 49Rituximab 46Dexamethasone 42Lenalidomide 41Ipilimumab 38Azacitidine 35Etoposide 34Cytarabine 33Temozolomide 32Bevacizumab 32Radiation 29venetoclax 28Bortezomib 27Magnetic Resonance Spectroscopy 26Irinotecan 26Pemetrexed 25atezolizumab 24Oxaliplatin 24Capecitabine 24fludarabine phosphate 22Filgrastim 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Terminated × ixabepilone × Clear all
NCT01012362 2017-12-28

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
31 enrolled 12 charts
BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT00632424 2016-03-10

Phase 1 Trial of Oral Ixabepilone

R-Pharm

Phase 1 Terminated
23 enrolled 11 charts
Other solid neoplasm

Advanced Solid Tumors

NCT00634088 2016-03-10

Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

R-Pharm

Phase 1 Terminated
13 enrolled 13 charts
Breast

Breast Neoplasms

NCT00028561 2013-01-17

BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Terminated
45 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00804310 2012-03-28

UCDCC#207

University of California, Davis

Phase 1 Terminated
5 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡